Fujifilm announced the start of a phase II clinical trial of its influenza antiviral drug ‘Avigan’ Tablet for COVID-19 patients in the U.S.
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
USDA confirmed highly pathogenic H7N3 avian influenza in a commercial flock in Chesterfield County, South Carolina
On Apr. 9, 2020, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic H7N3 avian…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
BioAegis announced publication: ‘Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza’
On Dec. 12, 2019, BioAegis Therapeutics announced publication of new research findings with recombinant human plasma gelsolin in…
The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
DARPA funded a $21.9 gene modulation research initiative at Georgia Tech, targeting influenza pandemics
In Jun. 2019, Defense Advanced Research Projects Agency (DARPA) announced it had funded a $21.9 gene modulation research…
Vaccitech universal flu vaccine passed Phase 2b clinical development milestones
On Jun. 5, 2019, Vaccitech announced that it has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100)…
FDA approved use of the 05 mL dose of Sanofi’s Fluzone Quadrivalent influenza vaccine to include children age 6 through 35 months
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
CDC published ACIP’s 2018-19 influenza vaccination recommendations
On Aug. 24, 2018, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee’s (ACIP)…
CDC | Influenza | Life Science News | Vaccine
CDC published ACIP’s recommendations for use of quadrivalent live attenuated influenza vaccine (LAIV4) in 2018-19 influenza season
On Jun. 8, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
Medigen Vaccines and GC Pharma collaborated to commercialize quadrivalent influenza vaccine in Taiwan
On Apr. 23, 2018, Medigen Vaccine Biologics and GC Pharma entered an exclusive distribution agreement for GCC’s quadrivalent…
The American College of Obstetricians and Gynecologists released opinion on influenza vaccination in pregnancy
On Apr. 1, 2018, the American College of Obstetricians and Gynecologists released a committee opinion on influenza vaccination…
FDA | Influenza | Life Science News | Vaccine
FDA approved expanded pediatric age indication for Fluarix Quadrivalent influenza vaccine
On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
Biotechnology | CDC | Influenza | Vaccine
CDC published ACIP 2017-18 influenza vaccination recommendations
On Aug. 25, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
Biotechnology | CDC | Influenza | Life Science News | Non-Profit Research | Radiology | Stem Cell | Vaccine
CDC published ACIP recommendations for prevention and control ofﾠ Haemophilus influenzaeﾠ type b (Hib) ﾠdisease
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
Biotechnology | Diagnostics | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
WHO declared end to 2009 H1N1 influenza pandemic
On Aug. 10, 2010, WHO Director-General Dr Margaret Chan announced that the H1N1 influenza virus had moved into…
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
swine flu outbreak declared a national emergency
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
ACIP issued recommendations on the use of H1N1 influenza vaccines
On Jul. 31, 2009, the Immunization Practices Advisory Committee (ACIP) updates the 2008 recommendations regarding the use of…
WHO declared world at the start of 2009 influenza pandemic
On Jun. 11, 2009, the Dr. Margaret Chan, Director-General WHO, declared world now at the start of 2009…
HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
A novel influenza A (H1N1)pdm09 virus was detected first in the U.S. before spreading worldwide
On Apr. 15, 2009, a novel influenza A virus (then referred to as ‘swine origin influenza A virus’)…
Biotechnology | CDC | Diagnostics | Influenza | Life Science News | NIH | Therapeutics
CDC began a complex and multi-faceted response to the H1N1 pandemic
On Apr. 15, 2009, infection with the new influenza A virus (then referred to as ‘swine origin influenza…
The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…